X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

When Congress passed the health care reform legislation in 2010, it included the Physician Payments Sunshine Act, which requires biopharmaceutical manufacturers to report (and make public) annual payments made to physicians. Under this law, payments or “transfers of value” under $10 would not be reportable if the aggregate spend for the calendar year was less than $100. Once that threshold is reached, all payments are reportable. Many companies have put forth the effort to set up systems that allow them to begin posting payment information to their websites well before the federal mandated timeframes. Others are working diligently to get systems in place to allow them to meet the Jan. 1, 2012, compliance date. This has been no small feat for these companies, as current company systems are not organized around the necessity to report information this way.

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2017 ALM Media Properties, LLC. All Rights Reserved.